170 related articles for article (PubMed ID: 28670632)
1. Systemic Sunitinib Malate Treatment for Advanced Juxtapapillary Retinal Hemangioblastomas Associated with von Hippel-Lindau Disease.
Knickelbein JE; Jacobs-El N; Wong WT; Wiley HE; Cukras CA; Meyerle CB; Chew EY
Ophthalmol Retina; 2017; 1(3):181-187. PubMed ID: 28670632
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal analysis of retinal hemangioblastomatosis and visual function in ocular von Hippel-Lindau disease.
Toy BC; Agrón E; Nigam D; Chew EY; Wong WT
Ophthalmology; 2012 Dec; 119(12):2622-30. PubMed ID: 22906772
[TBL] [Abstract][Full Text] [Related]
3. A meta-analysis of different von Hippel Lindau mutations: are they related to retinal capillary hemangioblastoma?
Azimi F; Aghajani A; Khakpour G; Chaibakhsh S
Mol Genet Genomics; 2022 Nov; 297(6):1615-1626. PubMed ID: 36006455
[TBL] [Abstract][Full Text] [Related]
4. Clinical and Genetic Characteristics of Retinal Capillary Hemangioblastoma in Korean Patients.
Lee SH; Park KH; Woo SJ; Park SJ; Joo K
Korean J Ophthalmol; 2022 Dec; 36(6):543-549. PubMed ID: 36281577
[TBL] [Abstract][Full Text] [Related]
5. Detection of retinal microvascular changes in von Hippel-Lindau disease using optical coherence tomography angiography.
Lu Y; Wang JC; Zeng R; Nagata T; Katz R; Mukai S; Miller JB
PLoS One; 2020; 15(2):e0229213. PubMed ID: 32078656
[TBL] [Abstract][Full Text] [Related]
6. Juxtapapillary retinal capillary hemangioma: A clinical and histopathological case report.
Al-Essa RS; Helmi HA; Alkatan HM; Maktabi AMY
Int J Surg Case Rep; 2021 Feb; 79():227-230. PubMed ID: 33485171
[TBL] [Abstract][Full Text] [Related]
7. Comparison of optical coherence tomography angiography and fundus fluorescein angiography features of retinal capillary hemangioblastoma.
Sagar P; Rajesh R; Shanmugam M; Konana VK; Mishra D
Indian J Ophthalmol; 2018 Jun; 66(6):872-876. PubMed ID: 29786009
[TBL] [Abstract][Full Text] [Related]
8. Evolution of a juxtapapillary von Hippel-Lindau tumour examined by optical coherence tomography.
Grigoropoulos VG; Nikolaidis P; Emfietzoglou I; Theodossiadis PG; Theodossiadis GP
Clin Exp Optom; 2012 Mar; 95(2):237-40. PubMed ID: 22332650
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathology and CXCR4 expression in surgically excised retinal hemangioblastomas associated with von Hippel-Lindau disease.
Liang X; Shen D; Huang Y; Yin C; Bojanowski CM; Zhuang Z; Chan CC
Ophthalmology; 2007 Jan; 114(1):147-56. PubMed ID: 17070589
[TBL] [Abstract][Full Text] [Related]
10. Ophthalmological Aspects of von-Hippel-Lindau Syndrome.
Khan HA; Shahzad MA; Iqbal F; Awan MA; Khan QA; Saatci AO; Abbass A; Hussain F; Hussain SA; Ali A; Ali W
Semin Ophthalmol; 2021 Oct; 36(7):531-540. PubMed ID: 33780299
[No Abstract] [Full Text] [Related]
11. 3-D OCT angiographic evidence of Anti-VEGF therapeutic effects on retinal capillary hemangioma.
Otero-Marquez O; Chui TY; Pinhas A; Castanos Toral MV; Zhou DB; Migacz J; Rosen RB
Am J Ophthalmol Case Rep; 2022 Mar; 25():101394. PubMed ID: 35198818
[TBL] [Abstract][Full Text] [Related]
12. Successful Treatment of Von Hippel-Lindau (VHL) Disease-Associated Retinal Capillary Hemangioblastoma (RCH) with Belzutifan in a Pediatric Patient.
Jones AA; Schloemer NJ; Wirostko WJ
Retin Cases Brief Rep; 2023 Jul; ():. PubMed ID: 37463465
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal anti-vascular endothelial growth factor therapy with pegaptanib for advanced von Hippel-Lindau disease of the retina.
Dahr SS; Cusick M; Rodriguez-Coleman H; Srivastava SK; Thompson DJ; Linehan WM; Ferris FL; Chew EY
Retina; 2007 Feb; 27(2):150-8. PubMed ID: 17290195
[TBL] [Abstract][Full Text] [Related]
14. PARS PLANA VITRECTOMY IN ADVANCED CASES OF VON HIPPEL-LINDAU EYE DISEASE.
Krzystolik K; Stopa M; Kuprjanowicz L; Drobek-Slowik M; Cybulski C; Jakubowska A; Gronwald J; Lubiński J; Lubiński W
Retina; 2016 Feb; 36(2):325-34. PubMed ID: 26308528
[TBL] [Abstract][Full Text] [Related]
15. Clinical characterization of retinal capillary hemangioblastomas in a large population of patients with von Hippel-Lindau disease.
Wong WT; Agrón E; Coleman HR; Tran T; Reed GF; Csaky K; Chew EY
Ophthalmology; 2008 Jan; 115(1):181-8. PubMed ID: 17543389
[TBL] [Abstract][Full Text] [Related]
16. Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease.
Albiñana V; Escribano RMJ; Soler I; Padial LR; Recio-Poveda L; Villar Gómez de Las Heras K; Botella LM
Orphanet J Rare Dis; 2017 Jun; 12(1):122. PubMed ID: 28662711
[TBL] [Abstract][Full Text] [Related]
17. Combined therapy guided by multimodal imaging of fifteen retinal capillary hemangioblastomas in a monocular Von Hippel- Lindau syndrome case report.
Guo J; Du L; Zhou P; Guo X; Dai F; Jin X
BMC Ophthalmol; 2022 May; 22(1):205. PubMed ID: 35524216
[TBL] [Abstract][Full Text] [Related]
18. Retinal capillary hemangioma: a comparison of sporadic cases and cases associated with von Hippel-Lindau disease.
Singh AD; Nouri M; Shields CL; Shields JA; Smith AF
Ophthalmology; 2001 Oct; 108(10):1907-11. PubMed ID: 11581072
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological restoration of visual function in a zebrafish model of von-Hippel Lindau disease.
Ward R; Ali Z; Slater K; Reynolds AL; Jensen LD; Kennedy BN
Dev Biol; 2020 Jan; 457(2):226-234. PubMed ID: 30825427
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal bevacizumab for retinal capillary hemangioblastoma: A case series and literature review.
Slim E; Antoun J; Kourie HR; Schakkal A; Cherfan G
Can J Ophthalmol; 2014 Oct; 49(5):450-7. PubMed ID: 25284102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
